Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire April 01, 2024 at 08:00 AM EDT CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: 23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire April 01, 2024 at 08:00 AM EDT CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: 23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: 23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com